Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.
Grimsby Man Wins Lottery
Province Invests at Plowing Match
Thorold Reviewing Council Size, Makeup
Region's Planning Committee Approves Hoverlink
City Moves in on Parking Problem Area
St. Catharines Man Captured
Niagara Adding More Speed Cameras
Make Sex Offender Registry Public: Thorold